Biden Team Launches Website, Text Messages to Locate Vaccines
(Bloomberg) -- President Joe Biden's administration has launched a website, text-message tool and phone hotline to link Americans with Covid-19 shots near them as the pace of vaccination in the U.S. has plateaued.
An existing vaccine locater site, VaccineFinder.org, has relaunched as Vaccines.gov, along with a new Spanish-language equivalent, Vacunas.gov. People in the U.S. will be able to text their ZIP code to GETVAX (438829) or VACUNA (822862) to see locations near them with available doses, or call a toll-free number with service in more than 150 languages.
“We want to make it as easy as possible for people to get vaccinated,” Surgeon General Vivek Murthy said in a statement. “By making it easier to find a vaccine, we will help people take a big step towards protecting themselves against Covid-19 and returning to their lives.”
The move comes as U.S. vaccination levels plateau, signaling a diminishing pool of people who will actively seek out shots. In the past week, an average of 2.63 million doses a day have been administered, according to the Bloomberg Vaccine Tracker, compared with a high of 3 million a day several weeks ago. The campaign is now shifting focus to those who are either skeptical about vaccination or are harder to reach.
Jeff Zients, Biden's Covid-19 response coordinator, said at a briefing Friday that it's anticipated there will be “more of a balance” between supply and demand as the vaccination campaign moves forward.
“What's unexpected is how fast we've gotten here. We know this next phase won't be easy, but neither was getting to 220 million shots in arms in the first 100 days,” he said. “This next phase is very focused on making it even easier, continuing to build vaccine confidence and ensuring equity for all Americans.”
Finding Appointments
Vaccine appointments in the U.S. until now have involved a relatively ad hoc patchwork of states, cities and pharmacies that take bookings directly. The new federal initiatives are aimed at building on that.
The administration focused initially on boosting supply, with the idea that national websites weren't useful if there weren't enough shots available, an official familiar with the development of the vaccine program said. Now that supply has increased, the administration is turning its attention to building more channels to link people with shots, the official said.
Biden described this as a “new phase” in announcing that the country had hit his goal of administering 200 million shots in his first 100 days. The president didn't set a new goal.
The U.S. has administered 237 million doses so far, including just over 16 million under the Trump administration, with 55% of the adult population having received at least one dose.
The website, phone line and text-message tool will be targeted to hard-to-reach people or areas. The phone number will be touted in rural areas with spotty Internet coverage and the text tool on digital ads for younger people. The measures are aimed in particular at younger people, those living in rural areas and people of color, the official said.
The Biden administration has consulted behavioral economists for advice, and was told to remove friction from the process, the official said.
The website allows people to select one, two or all of the three authorized U.S. vaccines, from Pfizer Inc., Moderna Inc. and Johnson & Johnson. Early data show that the vast majority of users choose all three, the official said.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.